Evidence-Based Blood Management (Video)
World's Largest Resource for Cardiovascular Perfusion
Cardiothoracic surgical leadership recently challenged the surgical community to achieve an operative mortality rate of 1.0% for the performance of isolated coronary artery bypass grafting (CABG). The purpose of our study was to identify a patient population in which this operative mortality goal is achievable relative to the estimated operative risk.
new so-called 'aprotinin-insensitive' ACT test (SaiACT) has been developed for the SONOCLOT analyzer. In this study we evaluated and compared this new test for the SONOCLOT analyzer in vitro with an established kaolin-based ACT from HEMOCHRON (HkACT).
This study examined the impact of hematocrit (HCT) on outcome following nonemergent coronary artery bypass grafting (CABG) and whether the association is modified by operative risk or intraoperative blood transfusion.